J. Goldman & Co’s Akso Health Group AHG Stock Holding History

J. Goldman & Co’s Portfolio AHG Stock Details AHG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-16,333	Closed	-$493K	–	256
2018 Q2	$493K	Buy	+16,333	New	+$556K	0.03%	287

Other funds holding AHG

KFA

Krane Funds Advisors New York $2.44B AUM 12.99% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

J. Goldman & Co's AHG Position: Q3 2018 in Review

J. Goldman & Co sold out of Akso Health Group (AHG) in Q3 2018, closing a stake of 16,333 shares — an estimated $493K sold.

J. Goldman & Co first reported a position in AHG in Q2 2018 and held it in 1 quarter. The position peaked at $493K in Q2 2018. 13 funds tracked by Wall St. Rank hold AHG as of Q3 2018.

J. Goldman & Co reported no remaining Akso Health Group position as of Q3 2018 after selling out during the quarter.
J. Goldman & Co sold 16,333 Akso Health Group shares in Q3 2018, an estimated $493K.
J. Goldman & Co first reported a position in Akso Health Group in Q2 2018 and held it in 1 quarter.
J. Goldman & Co's Akso Health Group position peaked at $493K in Q2 2018.
13 funds tracked by Wall St. Rank held Akso Health Group as of Q3 2018.

Based on J. Goldman & Co's 13F filing for Q3 2018, filed 14 Nov 2018.